Maintaining Fluid and Electrolyte Balance in Heart Failure

Veterinary Clinics of North America - Small Animal Practice

Volumn 38, Issue 3, 2008, Pages 727-745

  DeFrancesco, Teresa C ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTIARRHYTHMIC AGENT; BENAZEPRIL; BICARBONATE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DIURETIC AGENT; DOBUTAMINE; ENALAPRIL; FUROSEMIDE; GLUCONATE CALCIUM; GLUCONATE POTASSIUM; GLUCOSE; GLYCERYL TRINITRATE; HYDRALAZINE; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS SPIRONOLACTONE; INOTROPIC AGENT; INSULIN; LOOP DIURETIC AGENT; MAGNESIUM CHLORIDE; MAGNESIUM SULFATE; NITROPRUSSIDE SODIUM; PIMOBENDAN; POTASSIUM CHLORIDE; SILDENAFIL; SPIRONOLACTONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASODILATOR AGENT;

ANEMIA; ANIMAL DISEASE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; CONTINUOUS INFUSION; DISORDERS OF ACID BASE BALANCE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG WITHDRAWAL; ELECTROLYTE BALANCE; ELECTROLYTE DISTURBANCE; ERYTHROCYTE TRANSFUSION; FLUID BALANCE; FLUID RETENTION; FLUID THERAPY; HEART FAILURE; HEMODYNAMIC MONITORING; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; HYPERVISCOSITY SYNDROME; HYPERVOLEMIA; HYPOALBUMINEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPONATREMIA; HYPOVOLEMIA; KIDNEY INJURY; LUNG EDEMA; METABOLIC DISORDER; NONHUMAN; PATHOPHYSIOLOGY; PLASMAPHERESIS; PULMONARY HYPERTENSION; REVIEW; SODIUM RETENTION; UREMIA;

ANIMALS; CAT DISEASES; CATS; DOG DISEASES; DOGS; HEART FAILURE; WATER-ELECTROLYTE BALANCE; WATER-ELECTROLYTE IMBALANCE;

ANIMALIA;

EID: 41549155480     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cvsm.2008.02.005     Document Type: Review

References (45)

1. Guyton A.C., and Hall J.E. Textbook of medical physiology (1996), W.B. Saunders, Philadelphia p. 265-74, 496-7
2. Acute and short-term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with naturally acquired heart failure: results of the Invasive Multicenter PROspective Veterinary Evaluation of Enalapril study. The IMPROVE Study Group. J Vet Intern Med 9 (1995) 234-242
3. Controlled clinical evaluation of enalapril in dogs with heart failure: results of the Cooperative Veterinary Enalapril Study Group. The COVE Study Group. J Vet Intern Med 9 (1995) 243-252
4. Hamlin R.L., Benitz A.M., Ericsson G.F., et al. Effects of enalapril on exercise tolerance and longevity in dogs with heart failure produced by iatrogenic mitral regurgitation. J Vet Intern Med 10 (1996) 85-87
5. Ettinger S.J., Benitz A.M., Ericsson G.F., et al. Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group. J Am Vet Med Assoc 213 (1998) 1573-1577
6. Pouchelon J.L. The effect of benazepril on survival times and clinical signs of dogs with congestive heart failure: results of a multicenter, prospective, randomized, double-blinded, placebo-controlled, long-term clinical trial. J Vet Cardiol 1 (1999) 7-18
7. Fuentes V.L., Corcoran B., French A., et al. A double-blinded, randomized, placebo-controlled study of pimobendan in dogs with dilated cardiomyopathy. J Vet Intern Med 16 (2002) 255-261
8. Smith P.J., French A.T., Van Israel N., et al. Efficacy and safety of pimobendan in canine heart failure caused by myxomatous mitral valve disease. J Small Anim Pract 46 (2005) 121-130
9. Lombard C.W., Jons O., and Bussadori C.M. Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs. J Am Anim Hosp Assoc 42 (2006) 249-261
10. Rose B.D., and Post T.W. Clinical use of diuretics. In: Rose B.D. (Ed). Clinical physiology of acid-base and electrolyte disorders (2001), McGraw-Hill, New York 447-477
11. Pitt B., Zannad F., Remme W.J., et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341 (1999) 709-717
12. Boswood A., and Murphy A. The effect of heart disease, heart failure, and diuresis on selected laboratory an electrocardiographic parameters in dogs. J Vet Cardiol 8 (2006) 1-9
13. + concentrations in small dogs with degenerative mitral valve disease. J Vet Cardiol 9 (2007) 103-108
14. Hillege H.L., Nitsch D., Pfeffer M.A., et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113 (2006) 671-678
15. Smith G.L., Lichtman J.H., Bracken M.B., et al. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol 47 (2006) 1987-1996
16. Adams Jr. K.F., Fonarow G.C., Emerman C.L., et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,00 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149 (2005) 209-216
17. Nicolle A.P., Chetboul V., Allerheiligen T., et al. Azotemia and glomerular filtration rate in dogs with chronic valvular disease. J Vet Intern Med 21 (2007) 943-949
18. Humbert M., Sitbon O., and Simonneau G. Treatment of pulmonary hypertension. N Engl J Med 351 (2004) 1425-1436
19. Sahara M., Takahashi T., Imai Y., et al. New insights in the treatment strategy for pulmonary hypertension. Cardiovasc Drugs Ther 20 (2006) 377-386
20. Kellum H.B., and Stepien R.L. Sildenafil citrate therapy in 22 dogs with pulmonary hypertension. J Vet Intern Med 21 (2007) 1258-1264
21. Binanay C., Califf R.M., Hasselblad V., et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. J Am Med Assoc 294 (2005) 1625-1633
22. Gheorghiade M., Rossi J.S., Cotts W., et al. Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE trial. Arch Intern Med 167 (2007) 1998-2005
23. Brady C.A., Hughes D., and Drobatz K.J. Association of hyponatremia and hyperglycemia with outcome in dogs with congestive heart failure. Journal of Veterinary Emergency and Critical Care 14 (2004) 177-182
24. Rose B.D., and Post T.W. Regulation of the effective circulating volume. In: Rose B.D. (Ed). Clinical physiology of acid-base and electrolyte disorders (2001), McGraw-Hill, New York 258-284
25. Podrid P.J. Potassium and ventricular arrhythmias. Am J Cardiol 65 (1990) 33E-44E
26. Adrogue H.J., and Madias N.E. Sodium and potassium in the pathogenesis of hypertension. N Engl J Med 356 (2007) 1966-1978
27. Syme H.M., Barber P.J., Markwell P.J., et al. Prevalence of systolic hypertension in cats with chronic renal failure at initial evaluation. J Am Vet Med Assoc 220 (2002) 1799-1804
28. Cobb M.A., and Mitchell A.R. Plasma electrolyte concentrations in dogs receiving diuretic therapy for cardiac failure. J Small Anim Pract 33 (1992) 526-529
29. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study (RALES)). Am J Cardiol 78 (1996) 902-907
30. de Denus S., Tardif J.C., White M., et al. Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction: a retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trials. Am Heart J 152 (2006) 705-712
31. Hollifield J.W. Magnesium depletion, diuretics and arrhythmias. Am J Med 82 (1987) 30-37
32. Laurant W.F., and Touyz R.M. Physiological and pathophysiological role of magnesium in the cardiovascular system: implications in hypertension. J Hypertens 18 (2000) 1177-1191
33. Zipes D.P., Camm A.J., Borggrefe M., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden death-executive summary. Eur Heart J 27 (2006) 2099-2140
34. Capes S.E., Hunt D., Malmberg K., et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systemic overview. Lancet 355 (2000) 773-778
35. Souverein P.C., Berard A., Van Staa T.P., et al. Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study. Heart 90 (2004) 859-865
36. Smith S.A., Tobias A.H., Fine D.M., et al. Corticosteroid-associated congestive heart failure in 12 cats. International Journal of Applied Research in Veterinary Medicine 2 3 (2004) 159-170
37. Rush J.E., Freeman L.M., Fenollosa N.K., et al. Population and survival characteristics of cats with hypertrophic cardiomyopathy: 260 cases (1990-1999). J Am Vet Med Assoc 220 2 (2002) 202-207
38. Ployngam T., Tobias A.H., Smith S.A., et al. Hemodynamic effects of methylprednisolone acetate administration in cats. Am J Vet Res 67 4 (2006) 583-587
39. Mehta J., and Singhal S. Hyperviscosity syndrome in plasma cell dyscrasias. Semin Thromb Hemost 29 (2003) 467-471
40. Mellor P.J., Haugland S., Murphy S., et al. Myeloma-related disorders in cats commonly present as extramedullary neoplasms in contrast to myeloma in human patients: 24 cases with clinical follow-up. J Vet Intern Med 20 (2006) 1376-1383
41. Matus R.E., Leifer C.E., Gordon B.R., et al. Plasmapheresis and chemotherapy of hyperviscosity syndrome associated with monoclonal gammopathy in the dog. J Am Vet Med Assoc 183 (1983) 215-218
42. Horwich T.B., Fonarow G.C., Hamilton M.A., et al. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 39 (2002) 1780-1786
43. Anand I., McMurray J.J., Whitmore J., et al. Anemia and its relationship to clinical outcome in heart failure. Circulation 110 (2004) 149-154
44. Yaphe W., Giovengo S., and Moise N.S. Severe cardiomegaly secondary to anemia in a kitten. J Am Vet Med Assoc 202 (1993) 961-964
45. Farabaugh A.E., Freeman L.M., Rush J.E., et al. Lymphocyte subpopulations and hematologic variables in dogs with congestive heart failure. J Vet Intern Med 18 (2004) 505-509